MB comment: Vaccine nut Bill Gates has hit a brick wall with his latest failed miracle malaria vaccine. In Africa’s largest-ever clinical trial, the vaccine was only 30% effective. But in the dumbed-down world of vaccines, that won’t stop this lemon. Glaxo (the vaccine’s manufacturer) says they won’t give up and the head of Bill Gates’ Vaccine Boondoggle Organization is going for booster shots.
That is the tried-and-true vaccine fanatic strategy for vaccine failure – more booster shots. Einstein said the definition of insanity is doing the same thing over and over and expecting different results. Einstein would probably crown Bill Gates as King Looney.
This study is a huge failure for the Gatesian/big pharma pseudo-scientific paradigm, which avows that meddling with the human immune system via toxic vaccine cocktails will provide magical solutions to vast public health problems. The vaccine approach to malaria eradication has failed.
No word on how many undernourished African kids Gates and his Glaxo minions killed or damaged in their mega vaccine trial using a ‘control vaccine’ as a placebo. That must be classified information. Since when did vaccines become placebos you might ask? Since vaccine manufacturers needed a dangerous substance to conceal the damage their experimental vaccines cause in clinical trials. Using saline solution or a sugar pill as a real placebo would expose the deaths and neurological damage caused by vaccine adverse reactions in the clinical trial. Gates and Glaxo can’t afford that, so they use a dangerous placebo so they can proclaim ‘adverse reactions were no different than placebo.’
Keep in mind Glaxo has already been convicted and fined by an Argentine court for killing 14 babies in a vaccine clinical trial and the Times of India reports that drug makers killed 211 patients during clinical trials in the first six months of 2012.
Malaria vaccine disappoints in trial in African babies
Reuters Nov 9, 2012
A GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa’s largest ever clinical trial.
The surprisingly poor result for the world’s first potential vaccine against malaria leaves uncertain whether it can have a useful role in fighting the mosquito-borne disease that kills hundreds of thousands of children a year.
Philanthropist Bill Gates, who has helped fund its development, said further data was needed to determine whether and how the vaccine might be used.
“The efficacy came back lower than we had hoped, but developing a vaccine against a parasite is a very hard thing to do,” he said in a statement …
Despite the limited success, Britain’s top drugmaker said it would push ahead with developing the vaccine, called RTS,S or Mosquirix, and GSK Chief Executive Andrew Witty said he still believed it would be an important tool in fighting malaria.
“We’ve been at this for 30 years, and we’re certainly not going to give up now,” Witty told a conference call …
“We will have to have more information to give us a clearer idea as to how useful this vaccine will be,” said Seth Berkley, CEO of the GAVI Alliance, which funds bulk-buy vaccination programs for poorer nations.
In particular, Berkley told Reuters he wanted to see longer-term data, including the effect of booster shots, and an analysis of how the vaccine performed in different settings …
Control measures such as insecticide-treated bednets, indoor spraying and anti-malaria drugs have helped cut malaria cases and deaths significantly in recent years, but experts say an effective vaccine is vital to completely overcome the disease.
Scientists around the world are working on other potential malaria vaccines but RTS,S is by far the furthest ahead in development.